UB Paderborn / Katalog / Suche / in CDI

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

Journal of the American College of Cardiology, 2017-06, Vol.69 (23), p.2779-2790

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

Journal of the American College of Cardiology, 2017-05, Vol.69 (20), p.2475-2484

2017

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

JAMA internal medicine, 2021-10, Vol.181 (10), p.1412

2021

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.1014-1022.e1

2017

Link zum Volltext

Verfügbarkeit prüfen

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

Chest, 2016-12, Vol.150 (6), p.1302-1312

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening

Clinical infectious diseases, 2022-01, Vol.74 (1), p.59-65

2022

Link zum Volltext

Verfügbarkeit prüfen

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013

Diabetes care, 2017-04, Vol.40 (4), p.468-475

2017

Link zum Volltext

Verfügbarkeit prüfen

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

JAMA : the journal of the American Medical Association, 2017-05, Vol.317 (18), p.1854

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012

JAMA : the journal of the American Medical Association, 2014-01, Vol.311 (4), p.368

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2019-07, Vol.200 (2), p.168-174

2019

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation ablation in practice: assessing CABANA generalizability

European heart journal, 2019-04, Vol.40 (16), p.1257-1264

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients

Ophthalmology (Rochester, Minn.), 2017-03, Vol.124 (3), p.352-358

2017

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Journal of the American Heart Association, 2016-06, Vol.5 (6), p.n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence

JAMA network open, 2019-10, Vol.2 (10), p.e1912869-e1912869

2019

Link zum Volltext

Verfügbarkeit prüfen

Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II

PloS one, 2015-05, Vol.10 (5), p.e0128063-e0128063

2015

Link zum Volltext

Verfügbarkeit prüfen

Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review

BMJ (Online), 2017-05, Vol.357, p.j1680

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

Journal of the American Heart Association, 2016-02, Vol.5 (2), p.n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures

The New England journal of medicine, 2009-08, Vol.361 (9), p.849-857

2009

Link zum Volltext

Verfügbarkeit prüfen

Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study

Diabetes technology & therapeutics, 2019-12, Vol.21 (12), p.702

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction

Journal of cardiovascular electrophysiology, 2019-05, Vol.30 (5), p.668-674

2019

Link zum Volltext

Verfügbarkeit prüfen

National trends in emergency department visits and hospitalizations for food‐induced anaphylaxis in US children

Pediatric allergy and immunology, 2018-08, Vol.29 (5), p.538-544

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000–2017

Resuscitation, 2020-10, Vol.155, p.55-64

2020

Link zum Volltext

Verfügbarkeit prüfen

Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

Journal of the American College of Cardiology, 2016-06, Vol.67 (25), p.3020-3021

2016

Link zum Volltext

Verfügbarkeit prüfen

Increasing Emergency Department Visits for Anaphylaxis, 2005-2014

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2017-01, Vol.5 (1), p.171-175.e3

2017

Link zum Volltext

Verfügbarkeit prüfen

Regulatory Review of Novel Therapeutics — Comparison of Three Regulatory Agencies

The New England journal of medicine, 2012-06, Vol.366 (24), p.2284-2293

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012

Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis

Atrial fibrillation ablation in practice: assessing CABANA generalizability

Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence

Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II

Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures

Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study

Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction

National trends in emergency department visits and hospitalizations for food‐induced anaphylaxis in US children

Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000–2017

Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

Increasing Emergency Department Visits for Anaphylaxis, 2005-2014

Regulatory Review of Novel Therapeutics — Comparison of Three Regulatory Agencies

Suchergebnisse filtern